LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • Quality System
      • CDMO Service
      • Quality Control
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

Nikkei Japan Reports the Status of MEDIPOST’s Stem Cell Research

2015/01/07
STEM CELL THERAPEUTIC

43% Increase in Dosage of CARTISTEM, for 4th Quarter of 2014 Year on Year

2014/12/30
STEM CELL THERAPEUTIC

MEDIPOST will set up a joint venture company in China

2014/12/10
STEM CELL THERAPEUTIC

Korean stem cells regenerate coach Hiddink’s worn-out knee cartilage

2014/11/06
STEM CELL THERAPEUTIC
MEDIPOST GMP Cell Manufacturing Facility

Lung disease stem cell treatment drug ‘PNEUMOSTEM’ application for US clinical trial

2014/08/12
STEM CELL THERAPEUTIC

Lung disease stem cell drug designated ‘orphan drug in development stage’

2014/07/29
STEM CELL THERAPEUTIC
MEDIPOST GMP Cell Manufacturing Facility

Stem Cell Drug ‘CARTISTEM’ Treatment Japanese Patent

2014/07/10
STEM CELL THERAPEUTIC

US patent for ‘CARTISTEM’ raw material stem cell differentiation capability selection technology

2014/05/15
STEM CELL THERAPEUTIC

Successful administration of stem cell dementia treatment drug ‘NEUROSTEM’

2014/04/28
STEM CELL THERAPEUTIC
MEDIPOST GMP Cell Manufacturing Facility

Japan patent for dementia treatment technology using stem cell

2014/04/17
STEM CELL THERAPEUTIC

Stem cell treatment ‘CARTISTEM’ patient cutting the 10 million line

2014/03/27
STEM CELL THERAPEUTIC

Stem cell cartilage differentiation technology Singapore patent

2014/03/18
STEM CELL THERAPEUTIC
Previous 1 … 5 6 7 8 9 10 Next

Latest News

MEDIPOST Recruits Local Experts to U.S. Subsidiary, Accelera…
2024/12/06
MEDIPOST Completes Administration for Phase 3 Clinical Trial…
2024/11/22
MEDIPOST Affiliate OmniaBio Hosts Opening Ceremony for New C…
2024/10/21
MEDIPOST Discusses CARTISTEM® Partnerships and Licensing Opp…
2024/10/14
MEDIPOST’s CARTISTEM® Reaches Milestone of treating 30,000 P…
2024/06/24

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Recruits Local Experts to U.S.…2024.12.06
MEDIPOST Completes Administration for Ph…2024.11.22
MEDIPOST Affiliate OmniaBio Hosts Openin…2024.10.21
MEDIPOST Discusses CARTISTEM® Partnershi…2024.10.14
MEDIPOST’s CARTISTEM® Reaches Milestone…2024.06.24

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST